Join
Live feed
·
PRReleasevia Quantisnow
Nanobiotix S.A. logo

NANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program at the 2024 Annual Meeting of the American Society for Clinical Oncology Followed by an Investor Conference Call

ByQuantisnow·Wall Street's wire, on your screen.
NBTX· Nanobiotix S.A.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NBTX (Nanobiotix S.A.) and more on Quantisnow.